Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
0.6830
-0.0512 (-6.97%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Celularity Market Cap
Celularity has a market cap or net worth of $19.77 million as of August 7, 2026. Its market cap has decreased by -75.66% in one year.
Market Cap
19.77M
Enterprise Value
88.31M
1-Year Change
-75.66%
Ranking
Category
Stock Price
$0.68
ChartMarket Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $19.77M, a decrease of -94.39%. That is a compound annual growth rate of -33.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 19.77M | -37.46% |
| Dec 31, 2025 | 31.61M | -32.41% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 21.02M |
| NextCure | 20.88M |
| Allarity Therapeutics | 20.84M |
| Marker Therapeutics | 20.51M |
| Cellectar Biosciences | 20.46M |
| Skye Bioscience | 20.21M |
| Werewolf Therapeutics | 20.15M |
| Daré Bioscience | 20.07M |